Cargando…
Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting
Three reported episodes of anaphylaxis, where 1:1000 adrenaline was not immediately obtainable, triggered us to assess its availability on all adult wards. We found adrenaline was unavailable on 50% of audited wards. A questionnaire for doctors and nurses revealed lack of knowledge on both the manag...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652734/ https://www.ncbi.nlm.nih.gov/pubmed/26734203 http://dx.doi.org/10.1136/bmjquality.u464.w346 |
_version_ | 1782401809147494400 |
---|---|
author | Meade, Susanna Douglas, Jenny |
author_facet | Meade, Susanna Douglas, Jenny |
author_sort | Meade, Susanna |
collection | PubMed |
description | Three reported episodes of anaphylaxis, where 1:1000 adrenaline was not immediately obtainable, triggered us to assess its availability on all adult wards. We found adrenaline was unavailable on 50% of audited wards. A questionnaire for doctors and nurses revealed lack of knowledge on both the management of anaphylaxis and location of emergency drugs. Given that anaphylaxis is a treatable but potentially fatal condition, we held a meeting to discuss the situation with senior pharmacists, resuscitation managers, and senior doctors. Our intervention was to advise the production of ‘anaphylaxis packs’ as part of the crash trolley kit. This was to be added to the laminated crash trolley check list and to include adrenaline, chlorphenamine, hydrocortisone, and the anaphylaxis algorithm. The aim was to improve ward stock, staff knowledge, and create a consistent location for emergency drugs, so minimising human error, and patient harm. With a PDSA approach we trialled the intervention on four pilot wards. The packs have now been dispersed trust-wide. Re-audit at four months showed 100% ward stock of anaphylaxis packs, more consistent drug location and improved staff knowledge. There were 17 coded incidents of anaphylaxis at this hospital in 2011, the actual figure likely being higher. We feel our project has greatly improved patient safety in this area. |
format | Online Article Text |
id | pubmed-4652734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | British Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46527342016-01-05 Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting Meade, Susanna Douglas, Jenny BMJ Qual Improv Rep BMJ Quality Improvement Programme Three reported episodes of anaphylaxis, where 1:1000 adrenaline was not immediately obtainable, triggered us to assess its availability on all adult wards. We found adrenaline was unavailable on 50% of audited wards. A questionnaire for doctors and nurses revealed lack of knowledge on both the management of anaphylaxis and location of emergency drugs. Given that anaphylaxis is a treatable but potentially fatal condition, we held a meeting to discuss the situation with senior pharmacists, resuscitation managers, and senior doctors. Our intervention was to advise the production of ‘anaphylaxis packs’ as part of the crash trolley kit. This was to be added to the laminated crash trolley check list and to include adrenaline, chlorphenamine, hydrocortisone, and the anaphylaxis algorithm. The aim was to improve ward stock, staff knowledge, and create a consistent location for emergency drugs, so minimising human error, and patient harm. With a PDSA approach we trialled the intervention on four pilot wards. The packs have now been dispersed trust-wide. Re-audit at four months showed 100% ward stock of anaphylaxis packs, more consistent drug location and improved staff knowledge. There were 17 coded incidents of anaphylaxis at this hospital in 2011, the actual figure likely being higher. We feel our project has greatly improved patient safety in this area. British Publishing Group 2013-02-27 /pmc/articles/PMC4652734/ /pubmed/26734203 http://dx.doi.org/10.1136/bmjquality.u464.w346 Text en © 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode |
spellingShingle | BMJ Quality Improvement Programme Meade, Susanna Douglas, Jenny Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting |
title | Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting |
title_full | Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting |
title_fullStr | Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting |
title_full_unstemmed | Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting |
title_short | Introduction of ‘Anaphylaxis Packs’ to improve patient safety in a hospital setting |
title_sort | introduction of ‘anaphylaxis packs’ to improve patient safety in a hospital setting |
topic | BMJ Quality Improvement Programme |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652734/ https://www.ncbi.nlm.nih.gov/pubmed/26734203 http://dx.doi.org/10.1136/bmjquality.u464.w346 |
work_keys_str_mv | AT meadesusanna introductionofanaphylaxispackstoimprovepatientsafetyinahospitalsetting AT douglasjenny introductionofanaphylaxispackstoimprovepatientsafetyinahospitalsetting |